Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research.
Fauci
Anthony S
AS
National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9000 Rockville Pike, Bldg. 31, Rm 7A05, Bethesda, MD 20892, USA.
D035843:Biomedical Research / Q000639:trends*; D006291:Health Policy; D006801:Humans; D054579:National Institute of Allergy and Infectious Diseases (U.S.); D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000453:epidemiology*; D014481:United States / Q000453:epidemiology